Radiotherapy With Immunotherapy for Systemic Effect in Myeloma (RISE-M)

Condition:   Multiple Myeloma Interventions:   Drug: Nivolumab 240mg;   Radiation: Radiation therapy Sponsor:   Weill Medical College of Cornell University Not yet recruiting

Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials